Celularity (CELUW) Net Margin (2020 - 2025)

Celularity (CELUW) reported Net Margin of 594.23% for Q4 2025, up 133761.0% year-over-year from N/an in Q4 2024, and down 36.08% quarter-over-quarter from 436.66% in Q3 2025.

Celularity (CELUW) Net Margin (2020 - 2025) Analysis & Trends

Celularity (CELUW) has 6 years of Net Margin data on file, last reported at 594.23% in Q4 2025.

  • Net Margin for Q4 2025 came in at 594.23%, up 133761.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 345.76% (down 18834.0% YoY), and the FY2025 annual result was 345.76%, down 23899.0% from the prior year.
  • Net Margin declined to 594.23% in Q4 2025 per CELUW's latest filing, from 436.66% in the prior quarter.
  • Over five years, Net Margin peaked at 1266.58% in Q2 2022 and troughed at 3063.73% in Q1 2021.
  • A 5-year average of 668.99% and a median of 300.5% in 2025 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2023: Net Margin jumped 328474 bps in 2022, then tumbled 289861 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 83.2% in 2021, then soared by 811 bps to 591.77% in 2022, then plunged by 87 bps to 78.82% in 2023, then plunged by 2551 bps to 1931.83% in 2024, then surged by 69 bps to 594.23% in 2025.
  • Business Quant data shows CELUW's Net Margin at 594.23% in Q4 2025, 436.66% in Q3 2025, and 427.6% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Celularity - - -3.27 Mn -594.23%

Historic Data

Download Data
DateValue
Dec 31, 2025 -594.23%
Sep 30, 2025 -436.66%
Jun 30, 2025 -427.60%
Mar 31, 2025 -173.40%
Dec 31, 2024 -1,931.83%
Sep 30, 2024 -173.19%
Jun 30, 2024 -53.57%
Mar 31, 2024 -149.94%
Dec 31, 2023 78.82%
Sep 30, 2023 -2,479.56%
Jun 30, 2023 -1,632.03%
Mar 31, 2023 -1,626.86%
Dec 31, 2022 591.77%
Sep 30, 2022 116.06%
Jun 30, 2022 1,266.58%
Mar 31, 2022 -1,059.26%
Dec 31, 2021 -83.20%
Sep 30, 2021 470.14%
Jun 30, 2021 -2,018.16%
Mar 31, 2021 -3,063.73%